Theriva Biologics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Theriva Biologics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2022.
  • Theriva Biologics, Inc. Operating Lease, Payments for the quarter ending September 30, 2022 was $142K, a 77.5% increase year-over-year.
  • Theriva Biologics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2022 was $480K, a 51.4% increase year-over-year.
  • Theriva Biologics, Inc. annual Operating Lease, Payments for 2021 was $321K, a 3.88% increase from 2020.
  • Theriva Biologics, Inc. annual Operating Lease, Payments for 2020 was $309K, a 3% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $480K $142K +$62K +77.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $418K $144K +$64K +80% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $354K $112K +$33K +41.8% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $321K $82K +$4K +5.13% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-16
Q3 2021 $317K $80K +$3K +3.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $314K $80K +$3K +3.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $311K $79K +$2K +2.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $309K $78K +$3K +4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 $306K $77K +$2K +2.67% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $304K $77K +$2K +2.67% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $302K $77K +$2K +2.67% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $300K $75K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 $75K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $75K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $75K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.